Legal & General Group Plc - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 78 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$859,000
-25.5%
226,016
-0.3%
0.00%0.0%
Q4 2019$1,153,000
+8.8%
226,590
+8.1%
0.00%0.0%
Q3 2019$1,060,000
-12.9%
209,699
+6.2%
0.00%0.0%
Q2 2019$1,217,000
+32.9%
197,4370.0%0.00%0.0%
Q1 2019$916,000
+23.1%
197,437
+10.2%
0.00%0.0%
Q4 2018$744,000
-33.5%
179,2190.0%0.00%0.0%
Q3 2018$1,119,000
-4.5%
179,219
+23.2%
0.00%0.0%
Q2 2018$1,172,000
+21.3%
145,420
+11.8%
0.00%0.0%
Q1 2018$966,000
+25.3%
130,100
+0.3%
0.00%0.0%
Q4 2017$771,000
-17.0%
129,657
+2.6%
0.00%0.0%
Q3 2017$929,000
+7.3%
126,326
-0.9%
0.00%0.0%
Q2 2017$866,000
-21.3%
127,423
+9.4%
0.00%0.0%
Q1 2017$1,100,000
+633.3%
116,476
+576.8%
0.00%
Q4 2016$150,000
+114.3%
17,209
+47.3%
0.00%
Q3 2016$70,000
+32.1%
11,684
-8.6%
0.00%
Q2 2016$53,000
-3.6%
12,7900.0%0.00%
Q1 2016$55,000
-30.4%
12,7900.0%0.00%
Q4 2015$79,000
+11.3%
12,7900.0%0.00%
Q3 2015$71,000
-20.2%
12,7900.0%0.00%
Q2 2015$89,000
+17.1%
12,7900.0%0.00%
Q1 2015$76,000
-18.3%
12,7900.0%0.00%
Q4 2014$93,000
+43.1%
12,7900.0%0.00%
Q3 2014$65,00012,7900.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
Broadfin Capital, LLC 8,951,169$54,871,0003.38%
Virtus ETF Advisers LLC 103,807$636,0001.75%
BKS ADVISORS, LLC 291,150$1,785,0000.92%
Piermont Capital Management Inc. 363,549$2,229,0000.71%
TUDOR INVESTMENT CORP ET AL 2,370,760$14,532,0000.41%
SEARLE & CO. 60,000$349,0000.34%
TURNER INVESTMENTS LLC 252,785$1,550,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 891,672$5,466,0000.31%
Phocas Financial Corp. 635,333$3,895,0000.30%
TFS CAPITAL LLC 398,283$2,441,0000.26%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders